Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
- PMID: 10376981
- PMCID: PMC2362379
- DOI: 10.1038/sj.bjc.6690495
Aberrant DNA methylation of the p16INK4a gene in plasma DNA of breast cancer patients
Abstract
Hypermethylation of exon 1 of p16INK4a was examined in tumour and plasma DNA of a series of breast cancer patients. De novo methylation was observed in the tumours of eight patients (23%), and in plasma DNA in five (14%) of these eight patients. Our data show that de novo methylation of exon 1 of p16INK4a can be demonstrated in plasma DNA of breast cancer patients, a fact that provides additional evidence of the tumour-related origin of free plasma DNA in cancer patients.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical